EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:192509 - foslevodopa
| Formula | C9H12NO7P |
| Net Charge | 0 |
| Average Mass | 277.169 |
| Monoisotopic Mass | 277.03514 |
| SMILES | N[C@@H](Cc1ccc(OP(=O)(O)O)c(O)c1)C(=O)O |
| InChI | InChI=1S/C9H12NO7P/c10-6(9(12)13)3-5-1-2-8(7(11)4-5)17-18(14,15)16/h1-2,4,6,11H,3,10H2,(H,12,13)(H2,14,15,16)/t6-/m0/s1 |
| InChIKey | YNDMEEULGSTYJT-LURJTMIESA-N |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Applications: | antiparkinson drug A drug used in the treatment of Parkinson's disease. prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| foslevodopa (CHEBI:192509) has functional parent L-dopa (CHEBI:15765) |
| foslevodopa (CHEBI:192509) has role antiparkinson drug (CHEBI:48407) |
| foslevodopa (CHEBI:192509) has role prodrug (CHEBI:50266) |
| foslevodopa (CHEBI:192509) is a O-phosphoamino acid (CHEBI:21968) |
| foslevodopa (CHEBI:192509) is a L-tyrosine derivative (CHEBI:27177) |
| foslevodopa (CHEBI:192509) is a non-proteinogenic L-α-amino acid (CHEBI:83822) |
| Incoming Relation(s) |
| ABBV-951 (CHEBI:192512) has part foslevodopa (CHEBI:192509) |
| IUPAC Name |
|---|
| 3-hydroxy-O-phosphono-L-tyrosine |
| Synonyms | Source |
|---|---|
| levodopa-4'-monophosphate | ChemIDplus |
| (2S)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl]propanoic acid | IUPAC |
| Registry Numbers | Sources |
|---|---|
| CAS:97321-87-4 | ChemIDplus |
| Citations |
|---|